# Arterial Line Patency in ICU Bound COVID-19 Patients

> **NCT04992221** · — · COMPLETED · sponsor: **Hamad Medical Corporation** · enrollment: 245 (actual)

## Conditions studied

- SARS-CoV-2 ICU Bound

## Interventions

- **PROCEDURE:** arterial line

## Key facts

- **NCT ID:** NCT04992221
- **Lead sponsor:** Hamad Medical Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-01
- **Primary completion:** 2022-03-31
- **Final completion:** 2022-04-01
- **Target enrollment:** 245 (ACTUAL)
- **Last updated:** 2022-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04992221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04992221, "Arterial Line Patency in ICU Bound COVID-19 Patients". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04992221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*